2937: Hormones/ derivatives thereof used as hormones/ other steroids
COMESA
293711
Somatotropin, its derivatives & structural analogues
293712
Insulin & its salts
293719
Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
293721
Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
293722
Halogenated derivatives of corticosteroidal hormones
293723
Oestrogens & progestogens
293729
Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
293731
Epinephrine
293739
Catecholamine hormones other than epinephrine, their derivatives & structural analogues
293740
Amino-acid derivatives
293750
Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
293790
Hormones, prostaglandins, thromboxanes & leukotrienes, natural/reproduced by synthesis(excl. of 2937.11-2937.50); derivatives & structural analogues thereof, including chain modified polypeptides, used primarily as hormones
Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:
- The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
- The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
- Manufacture from materials classified in a heading other than that of the product
SADC
293711
Somatotropin, its derivatives & structural analogues
293712
Insulin & its salts
293719
Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
293721
Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
293722
Halogenated derivatives of corticosteroidal hormones
293723
Oestrogens & progestogens
293729
Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
293731
Epinephrine
293739
Catecholamine hormones other than epinephrine, their derivatives & structural analogues
293740
Amino-acid derivatives
293750
Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
293790
Hormones, prostaglandins, thromboxanes & leukotrienes, natural/reproduced by synthesis(excl. of 2937.11-2937.50); derivatives & structural analogues thereof, including chain modified polypeptides, used primarily as hormones
- Manufacture in which all the materials used are classified within a heading other than that of the product
EAC
293711
Somatotropin, its derivatives & structural analogues
293712
Insulin & its salts
293719
Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
293721
Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
293722
Halogenated derivatives of corticosteroidal hormones
293723
Oestrogens & progestogens
293729
Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
293731
Epinephrine
293739
Catecholamine hormones other than epinephrine, their derivatives & structural analogues
293740
Amino-acid derivatives
293750
Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
293790
Hormones, prostaglandins, thromboxanes & leukotrienes, natural/reproduced by synthesis(excl. of 2937.11-2937.50); derivatives & structural analogues thereof, including chain modified polypeptides, used primarily as hormones
Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:
- The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
- The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
- Manufacture from materials classified within a heading other than that of the product - Manufacture from any other heading is recognized as a substantial process.
EU GSP
293711
Somatotropin, its derivatives & structural analogues
293712
Insulin & its salts
293719
Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
293721
Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
293722
Halogenated derivatives of corticosteroidal hormones
293723
Oestrogens & progestogens
293729
Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
293731
Epinephrine
293739
Catecholamine hormones other than epinephrine, their derivatives & structural analogues
293740
Amino-acid derivatives
293750
Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
293790
Hormones, prostaglandins, thromboxanes & leukotrienes, natural/reproduced by synthesis(excl. of 2937.11-2937.50); derivatives & structural analogues thereof, including chain modified polypeptides, used primarily as hormones
- Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product
- Manufacture in which the value of all the materials used does not exceed 40% of the ex-works price of the product